Throne Jason 4
4 · IDEAYA Biosciences, Inc. · Filed Sep 14, 2023
Insider Transaction Report
Form 4
Throne Jason
VP, General Counsel
Transactions
- Sale
Common Stock
2023-09-12$30.01/sh−500$15,005→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-12−1,000→ 53,913 totalExercise: $12.86Exp: 2032-02-29→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2023-09-12$12.86/sh+1,000$12,860→ 1,000 total - Sale
Common Stock
2023-09-12$30.00/sh−500$15,000→ 500 total
Footnotes (2)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 29, 2023.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.